Ermelinda Helena Buqi Msra

Ermelinda Helena Buqi has extensive work experience in the field of regulatory affairs. Ermelinda Helena is currently working at Sarepta Therapeutics as an Associate Director of Global Regulatory Strategy, and previously held roles as a Senior Manager and Manager in the same department. Prior to joining Sarepta, Ermelinda worked at Takeda as a Manager in Global Regulatory Affairs, where they focused on Growth and Emerging Markets, as well as Quality and Compliance. Ermelinda also gained experience at Atrium Innovations as a Manager in International Regulatory Affairs, at Novartis Institutes for BioMedical Research in Scientific Operations and Global Regulatory Compliance, at Boston Heart Diagnostics in the Auto Chemistry and HDL LAB departments, and at Genzyme Genetics in Reproductive and Clinical Oncology/CS. At Genzyme Genetics, they were responsible for international accounts, building partnerships, and coordinating with various professionals in the field.

Ermelinda Helena Buqi holds a Master of Science (MS) degree in Regulatory Affairs - Strategic Regulatory Affairs from Northeastern University, which they obtained from 2018 to 2020. Prior to that, they completed a Master of Business Administration (MBA) in Business Administration and Management, General from Assumption University between 2013 and 2015. Ermelinda Helena'sundergraduate degree is in Biotechnology/Chemistry from Worcester State University, which they received from 2004 to 2008. Additionally, they hold various certifications such as Data Visualization: Storytelling from LinkedIn in 2021, GMP: Documentation and Records Keeping from BioPharma Institute in 2015, Six Sigma Black Belt Certification - CSSBB from Management Systems International in 2015, and Heart Saver CPR AED from the American Heart Association | American Stroke Association in March 2014.